Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C17H27NO2 |
| Molecular Weight | 277.4018 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC(CC)COC(=O)C1=CC=C(C=C1)N(C)C
InChI
InChIKey=WYWZRNAHINYAEF-UHFFFAOYSA-N
InChI=1S/C17H27NO2/c1-5-7-8-14(6-2)13-20-17(19)15-9-11-16(12-10-15)18(3)4/h9-12,14H,5-8,13H2,1-4H3
| Molecular Formula | C17H27NO2 |
| Molecular Weight | 277.4018 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionCurator's Comment: description was created based on several sources, including:
http://www.skincancer.org/prevention/sun-protection/sunscreen/the-skin-cancer-foundations-guide-to-sunscreens
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=352.50
http://www.ncbi.nlm.nih.gov/pubmed/10477339
Curator's Comment: description was created based on several sources, including:
http://www.skincancer.org/prevention/sun-protection/sunscreen/the-skin-cancer-foundations-guide-to-sunscreens
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=352.50
http://www.ncbi.nlm.nih.gov/pubmed/10477339
Padimate O is an organic compound related to the water-soluble compound PABA (4-aminobenzoic acid) that is used as an ingredient in some sunscreens. this chemical releases free radicals, damages DNA, has estrogenic activity, and causes allergic reactions in some people. Maximum FDA-approved concentration - 8%. Range of protection - UVB.
Originator
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Preventing | Unknown Approved UseLightens dark discolorations in the skin such as age spots, liver spots, freckles, minor scars and pigment in skin that may occur during pregnancy or from the use of oral contraceptives. Helps prevent sunburn. |
Doses
| Dose | Population | Adverse events |
|---|---|---|
10 % single, topical Highest studied dose |
healthy, ADULT Health Status: healthy Age Group: ADULT Sex: M Food Status: UNKNOWN Sources: |
Other AEs: Contact dematitis... |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Contact dematitis | 10 % single, topical Highest studied dose |
healthy, ADULT Health Status: healthy Age Group: ADULT Sex: M Food Status: UNKNOWN Sources: |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
OverviewOther
| Other Inhibitor | Other Substrate | Other Inducer |
|---|---|---|
Drug as perpetrator
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
| inconclusive [IC50 10.684 uM] | ||||
| no | ||||
| no | ||||
| no | ||||
| yes [IC50 13.4504 uM] | ||||
| yes [IC50 4.5646 uM] | ||||
| yes [IC50 6.9178 uM] | ||||
| yes [IC50 7.5637 uM] |
Tox targets
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| Dispersive liquid-liquid microextraction followed by gas chromatography-mass spectrometry for the rapid and sensitive determination of UV filters in environmental water samples. | 2010-09 |
|
| Photostability and phytotoxicity of selected sunscreen agents and their degradation mixtures in water. | 2009-11 |
|
| Determination of ink photoinitiators in packaged beverages by gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry. | 2008-06-20 |
|
| Determination of 2-isopropyl thioxanthone and 2-ethylhexyl-4-dimethylaminobenzoate in milk: comparison of gas and liquid chromatography with mass spectrometry. | 2007-09 |
|
| Fluorescence of sunscreens adsorbed to dielectric nanospheres: parallels to optical behavior on hacat cells and skin. | 2006-09-28 |
|
| Determination of sixteen UV filters in suncare formulations by high-performance liquid chromatography. | 2004-09-17 |
|
| Optical spectroscopy of hydrophobic sunscreen molecules adsorbed to dielectric nanospheres. | 2004-06 |
Patents
Sample Use Guides
Apply liberally 15 minutes before sun exposure. At least every 2 hours
Route of Administration:
Topical
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/10477339
Padimate-O reduces direct DNA damage in human keratinocytes from sunlight (UV-endonuclease-sensitive sites) from 4.32 to 1.52 (given as the number/megabase/kJ/m2).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:34:14 GMT 2025
by
admin
on
Mon Mar 31 17:34:14 GMT 2025
|
| Record UNII |
Z11006CMUZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C851
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m4524
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | Merck Index | ||
|
7169
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | |||
|
244-289-3
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | |||
|
1491503
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | |||
|
CHEMBL1323699
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | |||
|
Z11006CMUZ
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | |||
|
SUB169711
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | |||
|
4270
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | |||
|
Z11006CMUZ
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | |||
|
PADIMATE O
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | |||
|
21245-02-3
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | |||
|
100000159525
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | |||
|
DB11570
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | |||
|
DTXSID7029320
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | |||
|
30541
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | |||
|
C84038
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | |||
|
SUB14742MIG
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | |||
|
C041981
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | |||
|
32786
Created by
admin on Mon Mar 31 17:34:14 GMT 2025 , Edited by admin on Mon Mar 31 17:34:14 GMT 2025
|
PRIMARY | RxNorm |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
IMPURITY -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |